
April 9 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:
TONIX PHARMACEUTICALS AND MAKANA THERAPEUTICS ANNOUNCE COLLABORATION COMBINING TONIX’S ANTI-CD40L MONOCLONAL ANTIBODY (TNX-1500) WITH MAKANA’S GENETICALLY ENGINEERED ORGANS IN PRECLINICAL AND CLINICAL XENOTRANSPLANTATION STUDIES